See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Tariffs
Natural Disasters
Social Media
Donald Trump
Soccer
Trade War
Baseball
Floods
US Politics
Tennis
Trade
Amazon
Published • loading... • Updated

SK bioscience expands vaccine shipments to southern hemisphere market

Summary by The Korea Times
SK bioscience, a biopharmaceutical arm of Korea's SK Group, said Wednesday it will supply 750,000 doses of influenza vaccines to the southern hemisphere market in the first half.

2 Articles

All
Left
1
Center
Right
The Korea TimesThe Korea Times
Lean Left

SK bioscience expands vaccine shipments to southern hemisphere market

SK bioscience, a biopharmaceutical arm of Korea's SK Group, said Wednesday it will supply 750,000 doses of influenza vaccines to the southern hemisphere market in the first half.

·Korea, Republic of
Read Full Article
pirbright.ac.ukpirbright.ac.uk

CVIM partners Quantoom Biosciences to advance vaccine development

CVIM partners Quantoom Biosciences to advance vaccine development Chelsea Snell Thu 13/03/2025

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Left
100% Left
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

The Korea Times broke the news in Korea, Republic of on Wednesday, March 12, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Seoul

Seoul

Pirbright

Pirbright

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

News
For You
SearchBlindspotLocal